Tan said IHH has developed a 100-day turnaround plan to improve the operating margins by around 500-600 basis points.

Legacy of Fortis & Manipal coming together is quite positive: Narayana Health

In an interview with CNBC-TV18, Ashutosh Raghuvanshi, VC, MD & Group CEO of Narayana Health spoke about the latest happenings in his company and sector.

Fortis: No decision on Manipal offer

Fortis Healthcare has received a non-binding indication interest from Manipal Health but no decision has been taken by board on Manipal offer. In an interview with CNBC-TV18, Sandeep Parekh, Founder of Finsec Law Advisors shared his views and outlook on the same.

Private sector filling up the vacuum in healthcare facilities: Wockhardt

After a scathing report from the National Pharmaceutical Pricing Authority (NPPA) highlighting huge margin mark ups in corporate hospital Fortis' in patient bills, there has been a growing call for regulating private hospitals. But is it feasible? On the side-lines of a book launch, Wockhardt Hospital’s Chairman Habil Khorakiwala said government is abdicating its responsibility by just expecting to regulate private sector.

Fortis Health expects SRL demerger to be completed in 6 months

Fortis Healthcare reported a healthy set of numbers for the third quarter. The firm clocked a revenue growth of over 10 percent compared to the corresponding quarter last fiscal.

Demonetisation: Fortis Health sales dip 10-15%; co looks at digital payment mode

Bhavdeep Singh, CEO, Fortis Healthcare says Fortis is looking at other payment options like digital wallets and is doing its best to not turn patients away.

SRL likely to be valued 25 times FY18 operating profit:Macquarie

Singhal sees significant opportunity for diagnositics players such as Dr Lal Path Labs, Thyrocare and SRL. Organised players are already gaining market share and companies which maintain quality standards will definitely do well, he says.

Won't see any transfer of debt in Fortis re-jig: CEO

The name of Fortis Malar will subsequently be changed to SRK. CNBC-TV18's Varinder Bansal caught up with Bhavdeep Singh, CEO, Fortis Healthcare, to get more details.

Fortis to get a makeover, demerge diagnostics business

The board of directors of Fortis Healthcare on Friday approved the demerger of its diagnostics business. Fortis will include its diagnostics business into Fortis Malar Hospitals which will later be renamed SRL, the company said in a filing to BSE.

Demerger of diagnostics business will help unlock value: Fortis

Fortis Healthcare's board has given an in-principle nod for the demerger of its diagnostics business. The demerger, on which a committee will take a decision on August 19, is an opportunity to unlock value, says CEO Bhavdeep Singh.

Fortis targets 20% EBIDTA margins in next 2-3 years

The healthcare company will rely on brownfield expansion for driving growth and is also exploring the de-merger or a possible listing of SRL Diagnostics arm, Chief Executive Officer Bhavdeep Singh told CNBC-TV18.

See low double-digit growth, two-fold rise in bed count: Fortis

The hospital's occupancy rate is hovering around 72-73%, which Singh claims is higher than the industry. In the diagnostic business, Fortis expects to see margins in the high 20s.

No new hopitals in near future, will spend on R&D: Fortis CEO

In an interview with CNBC-TV18, Bhavdeep Singh, CEO of Fortis said that there are no plans to add new hospitals in the near future but the company will spend majorly on medical equipments and technology.

To focus on cancer treatment, organ therapy: Fortis Health

CEO Bhavdeep says Fortis Healthcare is targetting a 20 percent increase in bed count over the next four to five years, annually.

Not looking at SRL Diagnostics' IPO: Fortis Healthcare

Fortis Healthcare Thursday reported a consolidated net profit of Rs 87.28 crore for the first quarter ended June 30, 2015-16, mainly on account of gains from divestment of international businesses.

See net debt fall on S'pore assets' sale proceeds: Fortis

Shivinder Singh, executive vice-chairman, Fortis Healthcare says the company clocked a growth of 12 percent this year in its India business at about Rs 970 crore.

No intent to exit all mkts but focus on India biz: Fortis

Post divestment the company is expected to cut down its debt to Rs 400 crore from the current Rs 900 crore.

Fortis to use proceeds from Dental Corp sale to pare debt

Fortis Healthcare will use the entire proceeds from its 64 percent stake in Dental Corporation Holdings Ltd (DC), Australia to pare debt, says Vishal Bali, Global CEO. The company's stake in DC will be sold to Bupa for 270 million Australian dollar (around Rs 1,554.36 crore) by March 2013.

Fortis aims significant debt reduction; to raise Rs 2000cr

In an interview to CNBC-TV18, Vishal Bali, global chief executive officer, Fortis Healthcare says the company is trying to take a lot of steps to reduce their overall debt. He says a committee has been set to reduce their debt levels.

Have raised S$510m through Religare Health Trust: Malvinder

Religare Health Trust, backed by Indian hospital chain Fortis Healthcare, has successful raised 510.7 million Singapore dollars in gross proceeds from its initial public offering (IPO) on the Singapore Exchange (SGX).

Fortis Health to acquire Fortis Health Intl for $665m

Healthcare major Fortis will acquire its Singapore-based arm Fortis Healthcare International for USD 665 million informed, the company’s chairman Malvinder Singh.

Fortis looking to go to 8-10 verticals in 10-15 countries

Fortis Healthcare India today announced an all-cash deal to acquire Fortis Healthcare International as part of its plan to merge India and international operations. CNBC-TV18 catches up with the Singh brothers, Malvinder and Shivinder Singh, to understand the rationale behind the deal and the way forward for the merged entity.

Merged unit will create excellent synergy: Malvinder Singh

Hospital chain Fortis Healthcare (India) will buy Singapore-based sister firm Fortis Healthcare International in a move to bring all of the group's health businesses under one firm, group Chairman Malvinder Singh said.

Fortis to get footprint in Vietnam market via new deal

Malvinder Singh, chairman of Fortis Healthcare said that this deal will make the company one of the leading international healthcare delivery service companies in this marked space.

Healthcare service tax may be passed onto customers: Fortis

Malvinder Singh, Chairman, Fortis Healthcare, in an interview on CNBC-TV18 gave his views on how he read the budget presented by finance minister Pranab Mukherjee for financial year 2011-12.